这种LRRK2 p.L1795F变种在欧洲人口中引起帕金森病
Lara M Lange1,2,3, Kristin Levine4,5, Susan H Fox6
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany. la.lange@uni-luebeck.de.
NPJ Parkinson's disease
|March 26, 2025
概括
研究人员发现了一种新的LRRK2 p.L1795F遗传变异,与自体主导帕金森病 (PD) 有关. 这一发现在多个家族和病例中发现,表明这种LRRK2突变在PD发展中的病原作用.
科学领域:
- 遗传学 是一个遗传学.
- 神经退行性疾病 神经退行性疾病
- 分子生物学分子生物学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 基因突变是自体主导帕金森病 (PD) 的最常见原因.
- 识别新型LRRK2变异对于理解PD病变发生和开发向疗法至关重要.
研究的目的:
- 研究LRRK2 p.L1795F变异在帕金森病中的作用.
- 要确定这种变异是否具有病原性,并有助于自体主导PD.
主要方法:
- 对超过5万个人的基因分析,以确定LRRK2 p.L1795F变异携带者.
- 哈普洛型分析以评估携带者之间的共同祖先.
- 临床数据审查,以比较表现与已知的LRRK2-PD形式.
主要成果:
- 该LRRK2 p.L1795F变种在三个家族和六个无关病例中被发现.
- 变种的携带者共享一个共同的哈普洛型,表明一个共同的祖先起源.
- 携带者的临床表现与其他形式的LRRK2相关帕金森病一致.
结论:
- 该LRRK2 p.L1795F变体是致病性,并导致自体主导帕金森病.
- 与这种变体相关的增强LRRK2激酶活性支持其在PD中的作用.
- 这一发现扩大了与帕金森病相关的LRRK2突变的范围.
相关概念视频
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Treatment
166
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Single Nucleotide Polymorphisms-SNPs
13.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.8K
Pleiotropy
38.8K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
38.8K


